Novo Ventures

Novo Ventures

Novo Ventures

Follow us
$83,000,000 Venture capital (Series C)
FinSMEs

Lava Therapeutics Raises $83M in Series C Financing

$44,000,000 Venture capital (Series C)
FinSMEs

ReViral Raises $44M in Series C Financing

Xconomy

NodThera Adds $55M to Advance Drugs to Better Regulate Inflammation

$55,000,000 Venture capital (Series B)
WSJ Venture Capital

Biotech Startup NodThera to Combat Inflammation With $55 Million Series B

PE HUB

VC-backed ReViral taps Musso as CFO

$50,000,000 Debt financing
FinSMEs

Unchained Labs Receives $50M in Debt Financing

$150,000,000 Venture capital (Series C)
PE HUB

Galera Therapeutics fetches $150 mln Series C

$55,000,000 Venture capital (Series B)
MedCity News , FinSMEs , PE HUB

ReViral closes $55 million Series B funding round for RSV drug

£28,000,000 Venture capital (Series A)
FinSMEs

NodThera Secures £28M in Series A Financing

Funding Health Science
€16,000,000 Venture capital
FinSMEs , PE HUB

Lava Therapeutics Raises €16M in First Funding

Funding Health Science
$13,000,000 Venture capital (Series C)
silicontap

Unchained Labs Gets $13M, Buys Trinean

$15,000,000 Venture capital (Series B)
FinSMEs

Galera Therapeutics Receives $15M from Sofinnova Ventures

Funding Health Science
$125,000,000 Post-IPO equity
MassDevice

Nevro announces $125m funding round

$5,000,000 Venture capital (Series B)
FinSMEs

Galera Therapeutics Raises $5M; Closes 42M Series B Round

Health Funding Science